View printer-friendly version << Back
MEDNAX Announces Acquisition of Anesthesiology Practice in New York

American Anesthesiology Division Makes Entry into Ninth State

FORT LAUDERDALE, Fla.--(BUSINESS WIRE)--Jun. 11, 2013-- MEDNAX, Inc., (NYSE: MD) today announced the acquisition of Anesthesia Group of Onondaga, P.C., a physician group practice based in Syracuse, New York, to MEDNAX’s American Anesthesiology division. The practice, which was acquired by one of the company's affiliated professional contractors in New York, is the first New York-based anesthesiology practice to join the division, which now consists of 20 practices throughout nine states.

Anesthesia Group of Onondaga is a private group practice that employs 20 anesthesiologists, 22 anesthetists and four other clinical and administrative staff. The practice provides services across a wide spectrum of subspecialty areas, including critical care, orthopedics, cardiac, obstetrics, pediatrics and acute pain management and has been the sole provider of anesthesia services to St. Joseph’s Hospital Health Center since 1975. Anesthesia Group of Onondaga also provides services to the hospital’s affiliated surgery centers, Northeast Surgery Center and North Medical Surgery Center.

“We believe that American Anesthesiology’s core values of commitment to quality of care, research and education and patient satisfaction are very much aligned with our own,” said Ralph Firestone, M.D., who will serve as medical director for the American Anesthesiology practice. “We found in them a partner that offered superior clinical expertise as well as business and administrative infrastructure to positively impact our practice and most importantly, our patient outcomes, which is essential in today’s uncertain healthcare environment.”

MEDNAX’s American Anesthesiology division consists of more than 1,650 anesthesia providers, including more than 675 physicians and 975 anesthetists practicing in Florida, Georgia, Michigan, New Jersey, New York, North Carolina, Tennessee, Texas, and Virginia.

MEDNAX’s Pediatrix Medical Group division currently provides neonatal intensive care services at St. Joseph’s Hospital.

This was a cash transaction, and it is expected to be immediately accretive to earnings. No additional terms of the transaction were disclosed.

With this acquisition, four physician group practices have become part of MEDNAX in 2013, three as part of American Anesthesiology, and one as part of Pediatrix Medical Group.


MEDNAX, Inc. is a national medical group comprised of the nation's leading providers of neonatal, maternal-fetal and pediatric physician subspecialty services as well as anesthesia services. Physicians and advanced practitioners practicing as part of MEDNAX are reshaping the delivery of care within their specialties and subspecialties, using evidence-based tools, continuous quality initiatives and clinical research to enhance patient outcomes and provide high-quality, cost-effective care. Pediatrix Medical Group, a unit of MEDNAX, was founded in 1979 and now includes neonatal physicians who provide services at more than 330 neonatal intensive care units, who collaborate with affiliated maternal-fetal medicine, pediatric cardiology and pediatric critical care physician subspecialists to provide a clinical care continuum. Pediatrix is also the nation's largest provider of newborn hearing screens. In 2007, MEDNAX expanded into anesthesia services. Today, American Anesthesiology includes more than 1,650 anesthesiologists and advanced practitioners who provide anesthesia care to patients in connection with surgical and other procedures as well as pain management. MEDNAX, through its affiliated professional corporations, employs more than 2,175 physicians in 34 states and Puerto Rico. Additional information is available at

Certain statements and information in this press release may be deemed to contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Forward-looking statements may include, but are not limited to, statements relating to our objectives, plans and strategies, and all statements, other than statements of historical facts, that address activities, events or developments that we intend, expect, project, believe or anticipate will or may occur in the future. These statements are often characterized by terminology such as “believe”, “hope”, “may”, “anticipate”, “should”, “intend”, “plan”, “will”, “expect”, “estimate”, “project”, “positioned”, “strategy” and similar expressions, and are based on assumptions and assessments made by MEDNAX’s management in light of their experience and their perception of historical trends, current conditions, expected future developments and other factors they believe to be appropriate. Any forward-looking statements in this press release are made as of the date hereof, and MEDNAX undertakes no duty to update or revise any such statements, whether as a result of new information, future events or otherwise. Forward-looking statements are not guarantees of future performance and are subject to risks and uncertainties. Important factors that could cause actual results, developments, and business decisions to differ materially from forward-looking statements are described in MEDNAX’s most recent Annual Report on Form 10-K and its Quarterly Reports on Form 10-Q, including the sections entitled “Risk Factors”, as well MEDNAX’s current reports on Form 8-K, filed with the Securities and Exchange Commission.

Source: MEDNAX, Inc.

David T. Parker, 954-384-0175, x 5300
Vice President, Investor Relations & Corporate Communications